Acord-cadru de furnizare antineoplazice
Buyer: SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA
- Published
- 1 September 2026
- Estimated value
- 15,465,509 RON
- Place of performance
- RO113
- Procedure
- Open procedure
- Notice number
- 00602049-2026
- Reference
- 8d1fa61b-890f-4fe1-9b0d-c2812f06b423
- Official source
- Official source
CPV codes
- 33652100Agentes antineoplásicos
Description
Achizitie ANTINEOPLAZICE 30 loturi conform caiet sarcini. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificari/informatiilor suplimentare in a 10-a zi inainte de termenul limita stabilit pentru depunerea ofertelor. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 18
Lots (30)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | AFLIBERCEPTUM fl 25mg/ml- 8 ml (200MG) | 33652100 Agentes antineoplásicos | 256,962 RON |
| 2 | AFLIBERCEPTUM fl 25mg/ml-4ml (100MG) | 33652100 Agentes antineoplásicos | 141,713 RON |
| 3 | AVELUMABUM CONC. PT. SOL. PERF 20mg/ml-10 ml (200mg) | 33652100 Agentes antineoplásicos | 3,877,140 RON |
| 4 | BEVACIZUMABUM-biosimilar conc pt sol perf 25mg/ml -fl 100 mg | 33652100 Agentes antineoplásicos | 42,014 RON |
| 5 | BEVACIZUMABUM-biosimilar conc pt sol perf 25mg/ml -fl 400 mg | 33652100 Agentes antineoplásicos | 318,368 RON |
| 6 | BEVACIZUMABUM-inovativ conc pt sol perf 25mg/ml -fl 100 mg | 33652100 Agentes antineoplásicos | 252,081 RON |
| 7 | BEVACIZUMABUM-inovativ conc pt sol perf 25mg/ml -fl 400 mg | 33652100 Agentes antineoplásicos | 1,273,472 RON |
| 8 | BLEOMYCINUM SULFAS pulb. sol inj/perf. 15.000 UI | 33652100 Agentes antineoplásicos | 39,424 RON |
| 9 | CISPLATINUM conc pt sol perf 1 mg/ml-fl 25 ml | 33652100 Agentes antineoplásicos | 13,848 RON |
| 10 | CYCLOPHOSPHAMIDUM CONC. PT. SOL. PERF 500 mg/ml | 33652100 Agentes antineoplásicos | 33,600 RON |
| 11 | CYCLOPHOSPHAMIDUM pulb.pt. sol perf iv 200mg | 33652100 Agentes antineoplásicos | 15,126 RON |
| 12 | DOXORUBICINUM conc pt sol perf 10 mg-fl 5ml | 33652100 Agentes antineoplásicos | 3,552 RON |
| 13 | DOXORUBICINUM conc pt sol perf 100 mg- fl 50 ml | 33652100 Agentes antineoplásicos | 36,144 RON |
| 14 | DOXORUBICINUM conc pt sol perf 20 mg-fl 10ml | 33652100 Agentes antineoplásicos | 10,706 RON |
| 15 | DOXORUBICINUM conc pt sol perf 200 mg-100ml | 33652100 Agentes antineoplásicos | 56,450 RON |
| 16 | DOXORUBICINUM conc pt sol perf 50 mg- fl 25 ml | 33652100 Agentes antineoplásicos | 9,687 RON |
| 17 | DOXORUBICINUM pulb.conc.disp lipozom pt perf 50mg x 2 seturi (cu 3 fl/set) | 33652100 Agentes antineoplásicos | 35,178 RON |
| 18 | DURVALUMABUM CONC. PT. SOL. PERF 50 mg/ml, fl a 2,4 ml conc. (care conţine 120 mg durvalumab) | 33652100 Agentes antineoplásicos | 222,163 RON |
| 19 | DURVALUMABUM CONC. PT. SOL. PERF 50 mg/ml, fl la 10 ml conc. (care conţine 500 mg durvalumab) | 33652100 Agentes antineoplásicos | 916,562 RON |
| 20 | GEMCITABINUM conc pt sol perf 100 mg/ml-fl 15 ml | 33652100 Agentes antineoplásicos | 35,846 RON |
| 21 | IRINOTECANUM 4,3 mg/ml)CONC. PT. DISPERSIE PERF.-10ml | 33652100 Agentes antineoplásicos | 592,418 RON |
| 22 | METHOTREXAT sol inj 5000 mg/50 ml | 33652100 Agentes antineoplásicos | 35,639 RON |
| 23 | ONKO BCG 100 pulbere si solvent pentru suspensie intravezicla | 33652100 Agentes antineoplásicos | 618,400 RON |
| 24 | PEMBROLIZUMABUM conc.pt.sol.perf 25mg/ml-4ml (100mg) | 33652100 Agentes antineoplásicos | 4,606,432 RON |
| 25 | RAMUCIRUMABUM CONC. PT. SOL. PERF 10mg/ml x 2 fl/cutie | 33652100 Agentes antineoplásicos | 334,718 RON |
| 26 | TRABECTEDINUM PULB. PT.CONC. PT.SOL. PERF 0.25mg | 33652100 Agentes antineoplásicos | 134,373 RON |
| 27 | TRABECTEDINUM PULB. PT.CONC. PT.SOL. PERF 1mg | 33652100 Agentes antineoplásicos | 761,973 RON |
| 28 | TRASTUZUMABUM DERUXTECANUM pulb.pt.conc.pt. sol.perf. 100 mg | 33652100 Agentes antineoplásicos | 783,511 RON |
| 29 | VINBLASTINUM SOL INJ.1mg/ml-10ml | 33652100 Agentes antineoplásicos | 5,341 RON |
| 30 | VINCRISTINUM PULB. PT. SOL. INJ./PERF. I V 1mg-10ml | 33652100 Agentes antineoplásicos | 2,670 RON |
Award criteria
- Price — Pretul cel mai scazut este singurul criteriu
Awards
| Awarded to | Amount | Date |
|---|---|---|
| FILDAS TRADING S.R.L. | 4,638,740 RON | — |
| FARMEXIM S.A. | 4,602,576 RON | — |
| MEDIPLUS EXIM | 4,597,236 RON | — |
| MEDIPLUS EXIM | 3,856,116 RON | — |
| FARMEXIM S.A. | 3,850,392 RON | — |
| MERCK ROMANIA S.R.L. | 3,841,140 RON | — |
| MEDIPLUS EXIM | 1,222,176 RON | — |
| EUROPHARM HOLDING S.A. | 1,217,928 RON | — |
| FARMEXIM S.A. | 1,205,028 RON | — |
| MEDIPLUS EXIM | 908,616 RON | — |
Official publications
- TED · 00602049-2026 · 1 September 2026
- OJS · 168/2026 · 1 September 2026
Other tenders from SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA
- ACORD-CADRU DE FURNIZARE REACTIVI DE LABORATOR 1
- Acord-cadru de furnizare medicamente pentru programul de Hemodializa
- Acord-cadru de furnizare antineoplazice
- Acord-cadru furnizare medicament pentru sistemul musculo-scheletic -Nusinersenum sodic, solutie injectabila 12 mg, flacon 5 ml
- Acord-cadru furnizare ANTINEOPLAZICE
- ACORD-CADRU DE FURNIZARE ECHIPAMENTE MEDICALE DE PROTECTIE
- ACORD-CADRU DE FURNIZARE REACTIVI DE LABORATOR 2
- ACORD-CADRU DE FURNIZARE CONSUMABILE PENTRU DIALIZA RENALA
- ACORD-CADRU DE FURNIZARE REACTIVI DE LABORATOR 8
- ACORD-CADRU DE FURNIZARE REACTIVI DE LABORATOR 8
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is 15,465,509 RON.
- Who is the buyer of this tender?
- The contracting authority is SPITALUL CLINIC MUNICIPAL CLUJ-NAPOCA (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.